GlassScriptPhysician profile
Michael L Franklin
NPI 1346210663
$7,547.67
in general payments reported to CMS, 2019-2025
47 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,666 · 2022: $1,580 · 2023: $1,486 · 2024: $1,664 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,239 · Education: $62.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,239.17 |
| Education | $62.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,157.91 | 2021-2025 | |
| Novo Nordisk INC | $976.91 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $669.18 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $592.25 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Astrazeneca Pharmaceuticals LP | $562.83 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $340.90 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Otsuka America Pharmaceutical, INC. | $331.31 | 2022-2025 | Rexulti, Abilify Asimtufii |
| Gilead Sciences, INC. | $262.39 | 2021-2023 | |
| Baxter Healthcare | $232.02 | 2022 | |
| Welch Allyn | $232.02 | 2021 | |
| Astellas Pharma US INC | $194.59 | 2023-2025 | Veozah, Myrbetriq |
| Biohaven Pharmaceutical Holding Company LTD. | $176.21 | 2022 | |
| Pfizer INC. | $171.26 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.16 | 2022-2025 | Xifaxan, Trulance |
| Idorsia Pharmaceuticals US INC | $141.39 | 2023-2024 | Quviviq |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.